Antigen targets of remission-inducing immune therapy are expressed on CML progenitor cells

di Biernacki, Melinda A., Marina, Ovidiu, Zhang, Wandi, Liu, Fenglong, Bruns, Ingmar, Cai, Ann, Neuberg, Donna, Canning, Christine M., Alyea, Edwin P., Soiffer, Robert J., Brusic, Vladimir, Ritz, Jerome, Wu, Catherine J.
Pubblicazione 2010

Effective posttransplant antitumor immunity is associated with TLR-stimulating nucleic acid–immunoglobulin complexes in humans

di Lin, Yun, Zhang, Li, Cai, Ann X., Lee, Mark, Zhang, Wandi, Neuberg, Donna, Canning, Christine M., Soiffer, Robert J., Alyea, Edwin P., Ritz, Jerome, Hacohen, Nir, Means, Terry K., Wu, Catherine J.
Pubblicazione 2011

Mutated BCR-ABL Generates Immunogenic T Cell Epitopes In CML Patients

di Cai, Ann, Keskin, Derin B., DeLuca, David S., Alonso, Anselmo, Zhang, Wandi, Zhang, Guang Lan, Hammond, Naa Norkor, Nardi, Valentina, Stone, Richard M., Neuberg, Donna, Sidney, John, Brusic, Vladimir, Wu, Catherine J.
Pubblicazione 2012

Serologic markers of effective tumor immunity against chronic lymphocytic leukemia include non-mutated B cell antigens

di Marina, Ovidiu, Hainz, Ursula, Biernacki, Melinda A., Zhang, Wandi, Cai, Ann, Duke-Cohan, Jonathan S., Liu, Fenglong, Brusic, Vladimir, Neuberg, Donna, Kutok, Jeffery L., Alyea, Edwin P., Canning, Christine M., Soiffer, Robert J., Ritz, Jerome, Wu, Catherine J.
Pubblicazione 2010

Characterization of golimumab, a human monoclonal antibody specific for human tumor necrosis factor α

di Shealy, David, Cai, Ann, Staquet, Kim, Baker, Audrey, Lacy, Eilyn R, Johns, Laura, Vafa, Omid, Gunn, George, Tam, Susan, Sague, Sarah, Wang, Dana, Brigham-Burke, Mike, Dalmonte, Paul, Emmell, Eva, Pikounis, Bill, Bugelski, Peter J, Zhou, Honghui, Scallon, Bernard, Giles-Komar, Jill
Pubblicazione 2010